Michael Griffin

Heparin - Disruption Risk Intelligence, Edition 1

VEROLYX Cross-Sector Disruption Intelligence Heparin Disruption Risk Intelligence — Edition 1 July 2026 1 AT A GLANCE Critical Heparin is a widely used anti-coagulant essential to cardiovascular surgery, dialysis, and clot prevention, making it a critical care drug with no easy substitute at scale. Demand is driven by rising

News

Coming soon

This is Verolyx Cross Sector Disruption Intelligence, a brand new site by Michael Griffin that's just getting started. Things will be up and running here shortly, but you can subscribe in the meantime if you'd like to stay up to date and receive emails when new